AI could make bioweapons easier to build. A rare coalition wants to stop that now.

DNA synthesis is vital to several processes in biopharmaceutical innovation, including the development of gene therapies, CRISPR gene editing, antisense oligonucleotides and RNA therapies. The need ...

Strategic partnership marks launch of early access program offering rapid, long, clonal gene synthesis and high-complexity genes up to 15 kb The partnership strengthens IDT’s robust synthetic biology ...

Elegen’s ENFINIA™ Linear DNA offers high-accuracy, double-stranded DNA up to 7kb with 99.999% accuracy. Its cell-free synthesis eliminates cloning, delivering NGS-verified sequences in 6–8 business ...

Support for screening does not depend on any one view of AI; the biosecurity case has long been recognized by scientists and ...

Matthew Hayes (Left) is the Chief Technology Officer and founder at Evonetix, a groundbreaking gene synthesis technology company created in 2015, where he deploys his expertise in multi-disciplinary ...

Johnson and Alistar competed as finalists in CU Boulder’s 2025 Lab Venture Challenge where their technology generated much interest from industry leaders. Access to DNA is crucial in many branches of ...

Last year, during the Global Synthetic Biology (SynBioBeta) conference, Ansa Biotechnologies’ CEO Jason Gammack introduced attendees to the company’s first product—600 bp synthetic DNA constructs.

DNA has tremendous potential as a data storage medium, but the process of synthesizing DNA from scratch is time-consuming. It has to be done one nucleotide at a time in a specific sequence. New ...